NOD-like Receptor (NLR)

NOD-like receptor (NLR) inhibitors and activators target cytosolic sensors of microbial and cellular danger signals. These receptors carry a nucleotide-binding oligomerization domain (NOD) and include NOD1, NOD2 and the NLR family pyrin domain-containing (NLRP) proteins. In 2001, a frameshift mutation in NOD2 was associated with susceptibility to Crohn's disease. Some NLRs, such as NLRP3, assemble inflammasomes, protein platforms that activate inflammatory caspases and process pro-interleukin-1β. MCC950 sodium was reported in 2015 as a selective small-molecule inhibitor of the NLRP3 inflammasome, whereas the ionophore nigericin sodium salt activates it. Mifamurtide, a synthetic muramyl dipeptide analog, acts on NOD2, and NOD-IN-1 inhibits NOD1 and NOD2.

5 Items

  • NEK7 degrader-1
    Cat. No.
    A25175

    NEK7 degrader-1

    NEK7 degrader-1 is a potent NEK7 degrader with a DC50 of 0.1 nM, specifically designed to modulate NF-kB signaling pathways. It effectively inhibits caspase-1 activity and reduces IL-1β release in macrophages upon NLRP3 inflammasome activation. This compound is applicable for research in autoinflammatory and autoimmune disorders, including multiple sclerosis, as well as neurodegenerative diseases like Alzheimer's disease, and metabolic disorders such as pericarditis and Type 2 diabetes.

    1 mg
    $1,055.00
    5 mg
    $2,705.00
    All 3 sizes
  • MC-ND-18
    Cat. No.
    A35615

    MC-ND-18

    MC-ND-18 is an ATTEC degrader targeting NLRP3, functioning primarily through autophagic pathways. With a DC50 value of 125.5 nM in THP-1 cells, this compound facilitates the selective degradation of NLRP3. Composed of a ligand specific to NLRP3, a linker, and an LC3 ligand, MC-ND-18 is valuable for research investigating inflammation and diseases associated with NLRP3 activation.

    Out of stock

    All 3 sizes
  • NEK7 degrader-2
    Cat. No.
    A35626

    NEK7 degrader-2

    NEK7 degrader-2 (Compound 25) is a targeted NEK7 degrader that facilitates dose-dependent degradation of NEK7 specifically in human PBMC-derived macrophages. This compound effectively reduces the release of pro-inflammatory cytokine IL-1β triggered by NLRP3 inflammasome activation. NEK7 degrader-2 serves as a valuable tool for investigating the mechanisms underlying inflammatory diseases.

    Out of stock

    All 3 sizes
  • NEK7 degrader-3
    Cat. No.
    A55080

    NEK7 degrader-3

    NEK7 degrader-3 is an orally active NEK7 molecular glue degrader with a DC50 of 33.1 nM, which effectively mediates the interaction between NEK7 and the E3 ligase cereblon, leading to the proteasomal degradation of NEK7. This degradation process attenuates NLRP3 inflammasome-mediated inflammatory responses, resulting in the inhibition of caspase-1 activity and the release of pro-inflammatory cytokines IL-1β, IL-1α, and IL-18. NEK7 degrader-3 demonstrates significant anti-inflammatory effects in LPS-induced neuroinflammation mouse models, serving as a valuable tool for research focused on neuroinflammation.

    Out of stock

    All 3 sizes
  • HDAC3 degrader-2
    Cat. No.
    A64899

    HDAC3 degrader-2

    HDAC3 Degrader-2 is a selective degrader of histone deacetylase 3 (HDAC3), functioning through targeted degradation to inhibit the activation of the NLRP3 inflammasome. By facilitating the reduction of IL-1β maturation and caspase-1 activity, HDAC3 Degrader-2 demonstrates significant anti-inflammatory effects. This reagent is applicable in researching conditions such as endotoxin shock, colitis, and gouty arthritis, providing valuable insights into mechanisms of inflammation and therapeutic interventions.

    Out of stock

    All 3 sizes

5 Items

Added to your cart

View Cart Checkout

    Loading...